Guest Host: Steve Roberts

A new study suggests antidepressants may be no more effective than placebo in all but severe cases of depression. A look at how drug effectiveness is measured and weighed against safety concerns in and beyond the drug approval process.

Guests

  • Dr. William Potter serves on the FDA's Psychopharmacologic Drugs Advisory Committee, vice president for translational neuroscience at Merck Research Laboratories; board-certified psychiatrist
  • Dr. Jerry Avorn Professor of Medicine at Harvard Medical School; Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital; author "Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs"
  • Blair Johnson professor of psychology, University of Connecticut; coauthor on new antidepressant study
  • Gardiner Harris science reporter for "The New York Times"

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

President-Elect Trump And U.S. Trade

Thursday, Dec 01 2016During the campaign President-elect Donald Trump promised to bring jobs back to the U.S. by changing the rules with our global trading partners: What stronger protectionist policies could mean for American workers and the U.S. economy.

“The Master Plan”: A New Look At ISIS’ Complex Hidden Past

Wednesday, Nov 30 2016Drawing from newly declassified documents, counterterrorism expert Brian Fishman makes the case for a new history of the origins of the Islamic State. He says the US has made critical mistakes in understanding the terror group to this point. Fishman and expert William McCants discuss the hidden past of ISIS, and what the new U.S. administration needs to know about it moving forward.